Minerva Neurosciences Inc (NERV)

Currency in USD
6.550
-0.990(-13.13%)
Closed·
6.510-0.040(-0.61%)
·
Unusual trading volume
NERV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.4208.048
52 wk Range
1.15012.460
Key Statistics
Prev. Close
6.55
Open
7.37
Day's Range
6.42-8.048
52 wk Range
1.15-12.46
Volume
681.38K
Average Volume (3m)
192.62K
1-Year Change
254.0541%
Book Value / Share
-3.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NERV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.250
Upside
+10.69%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Minerva Neurosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Compare NERV to Peers and Sector

Metrics to compare
NERV
Peers
Sector
Relationship
P/E Ratio
−1.0x−7.5x−0.5x
PEG Ratio
0.00−0.130.00
Price/Book
−2.0x6.8x2.6x
Price / LTM Sales
-10.9x3.1x
Upside (Analyst Target)
10.7%88.9%58.4%
Fair Value Upside
Unlock7.0%9.3%Unlock

Analyst Ratings

0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 7.250
(+10.69% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold7.00+6.87%4.00MaintainMar 12, 2026
H.C. Wainwright
Hold4.00-38.93%5.00MaintainNov 06, 2025

Earnings

Latest Release
Mar 11, 2026
EPS / Forecast
-0.64 / -0.11
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NERV Income Statement

People Also Watch

1.9800
HURA
+2.06%
1.1700
PRSO
-3.31%
11.08
BATL
-13.10%
4.59
ATOM
+8.00%
5.860
RLMD
-3.46%

FAQ

What Is the Minerva Neurosciences (NERV) Stock Price Today?

The Minerva Neurosciences stock price today is 6.550 USD.

What Stock Exchange Does Minerva Neurosciences Trade On?

Minerva Neurosciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Minerva Neurosciences?

The stock symbol for Minerva Neurosciences is "NERV."

What Is the Minerva Neurosciences Market Cap?

As of today, Minerva Neurosciences market cap is 283.450M USD.

What Is Minerva Neurosciences's Earnings Per Share (TTM)?

The Minerva Neurosciences EPS (TTM) is -34.670.

When Is the Next Minerva Neurosciences Earnings Date?

Minerva Neurosciences will release its next earnings report on May 06, 2026.

From a Technical Analysis Perspective, Is NERV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Minerva Neurosciences Stock Split?

Minerva Neurosciences has split 1 times.

How Many Employees Does Minerva Neurosciences Have?

Minerva Neurosciences has 7 employees.

What is the current trading status of Minerva Neurosciences (NERV)?

As of Mar 24, 2026, Minerva Neurosciences (NERV) is trading at a price of 6.550 USD, with a previous close of 6.550 USD. The stock has fluctuated within a day range of 6.420 USD to 8.048 USD, while its 52-week range spans from 1.150 USD to 12.460 USD.

What Is Minerva Neurosciences (NERV) Price Target According to Analysts?

The average 12-month price target for Minerva Neurosciences is 7.250 USD, with a high estimate of 7.5 USD and a low estimate of 7 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +10.69% Upside potential.

What Is the NERV After Hours Price?

NERV's last after hours stock price is 6.310 USD, the stock has decreased by -0.240, or -3.660%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.